In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin.

S-1090, a new oral cephalosporin, was active against selected gram-negative bacteria and methicillin-susceptible clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus warneri, against which it had excellent activity. S-1090 was the most active compound against St...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Tsuji, M, Ishii, Y, Ohno, A, Miyazaki, S, Yamaguchi, K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162981/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8585742/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.11.2544
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!